109 related articles for article (PubMed ID: 12854872)
1. In vivo effects of phosphodiesterase III inhibitors on glucose metabolism and insulin sensitivity.
Yang G; Li L
J Chin Med Assoc; 2003 Apr; 66(4):210-6. PubMed ID: 12854872
[TBL] [Abstract][Full Text] [Related]
2. Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion.
Cheung P; Yang G; Boden G
Metabolism; 2003 Nov; 52(11):1496-500. PubMed ID: 14624413
[TBL] [Abstract][Full Text] [Related]
3. Modulation of insulin secretion and glycemia by selective inhibition of cyclic AMP phosphodiesterase III.
Parker JC; VanVolkenburg MA; Nardone NA; Hargrove DM; Andrews KM
Biochem Biophys Res Commun; 1997 Jul; 236(3):665-9. PubMed ID: 9245710
[TBL] [Abstract][Full Text] [Related]
4. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
Li L; Yang GY
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of phosphodiesterase III with milrinone increases renin secretion in human subjects.
Chiu YJ; Hu SH; Reid IA
J Pharmacol Exp Ther; 1999 Jul; 290(1):16-9. PubMed ID: 10381754
[TBL] [Abstract][Full Text] [Related]
6. Ginseng extract inhibits lipolysis in rat adipocytes in vitro by activating phosphodiesterase 4.
Wang H; Reaves LA; Edens NK
J Nutr; 2006 Feb; 136(2):337-42. PubMed ID: 16424109
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect on insulin secretion from INS-1 cells of a sulfonylurea and a phosphodiesterase 3 inhibitor.
Parker JC; VanVolkenburg MA; Gao F
Life Sci; 2004 Aug; 75(12):1479-90. PubMed ID: 15240182
[TBL] [Abstract][Full Text] [Related]
8. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
Beierwaltes WH
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359
[TBL] [Abstract][Full Text] [Related]
9. Species-dependent pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 58993 and WIN 62005.
Dundore RL; Pagani ED; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
J Cardiovasc Pharmacol; 1995 Jan; 25(1):14-21. PubMed ID: 7723343
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase III inhibition affects platelet-monocyte aggregate formation depending on the axis of stimulation.
Horn NA; Anastase DM; Hecker KE; Baumert JH; Scheffer GJ; Rossaint R
J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):162-6. PubMed ID: 16616654
[TBL] [Abstract][Full Text] [Related]
11. The effect of phosphodiesterase III inhibitors on human neutrophil function.
Mikawa K; Akamatsu H; Nishina K; Shiga M; Maekawa N; Obara H; Niwa Y
Crit Care Med; 2000 Apr; 28(4):1001-5. PubMed ID: 10809273
[TBL] [Abstract][Full Text] [Related]
12. Effect of hepatic glucose production on acute insulin resistance induced by lipid-infusion in awake rats.
Li L; Yang GY
World J Gastroenterol; 2004 Nov; 10(21):3208-11. PubMed ID: 15457577
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, milrinone.
Kume M; Banafsche R; Yamamoto Y; Yamaoka Y; Nobiling R; Gebhard MM; Klar E
J Surg Res; 2006 Dec; 136(2):209-18. PubMed ID: 17045613
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 3 inhibitors selectively block the spontaneous resumption of meiosis by macaque oocytes in vitro.
Jensen JT; Schwinof KM; Zelinski-Wooten MB; Conti M; DePaolo LV; Stouffer RL
Hum Reprod; 2002 Aug; 17(8):2079-84. PubMed ID: 12151440
[TBL] [Abstract][Full Text] [Related]
15. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
16. Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by beta1- and beta2-adrenergic receptor activation in human myocardium.
Carceles MD; Fuentes T; Aroca V; Lopez J; Hernández J
Clin Ther; 2007 Aug; 29(8):1718-24. PubMed ID: 17919552
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
[TBL] [Abstract][Full Text] [Related]
18. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phosphodiesterase type III before aortic cross-clamping preserves intramyocardial cyclic adenosine monophosphate during cardiopulmonary bypass.
Janelle GM; Urdaneta F; Blas ML; Shryock J; Tang YS; Martin TD; Lobato EB
Anesth Analg; 2001 Jun; 92(6):1377-83. PubMed ID: 11375808
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of specific phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation.
Thomas RE; Armstrong DT; Gilchrist RB
Dev Biol; 2002 Apr; 244(2):215-25. PubMed ID: 11944932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
